Bioadhesive Matrix Technology Platform

Invention Summary

Oral mucositis is one of the most painful and challenging side effects of cancer treatment. It causes severe mouth sores that make eating, drinking, and even speaking incredibly difficult, often putting patients at risk for infection and malnutrition.

Unfortunately, standard treatments like liquid mouth rinses and lozenges just don't last; they are washed away almost immediately by saliva and the natural movement of the tongue. The Phoenix Project’s bioadhesive matrix changes that. By creating a protective, long-lasting barrier that stays exactly where it’s needed, working with your saliva instead of against it, we can finally provide consistent, reliable relief, giving your body the time and space it needs to actually heal.

The Phoenix Project introduces an innovative, patented technology platform (U.S. Provisional Patent Application No. 63/993,997) engineered specifically to circumvent this clearance mechanism. The platform delivers a robust, localized bioadhesive matrix designed to mechanically shield damaged tissue, optimize the therapeutic interface, and significantly extend contact time at the targeted lesion site.

How it Works

I designed this approach to be flexible, so it can provide the right kind of relief depending on where and how you need it most. Whether you're dealing with a specific, sensitive area or need broader coverage, the goal remains the same: effective, comfortable protection that stays in place.

We offer four ways to apply this barrier, all engineered to work with your body's natural healing process:

• Solid Film / Topical Patch: A thin, precise barrier (0.3 mm) designed to stay put over localized, severe ulcers.
• Gel / Paste: A soft, adaptable formula that sticks easily to tricky or uneven areas of the mouth.
• Liquid Spray: A gentle, fine mist for broad, non-contact coverage, perfect for when touching the area is too painful.
• Powder Delivery Matrix: A targeted powder that activates and forms a protective layer the moment it touches moisture.

By establishing a physical boundary that withstands standard saliva flow rates and active tongue movement, this platform maintains structural integrity directly over ulcerated tissue, drastically mitigating the direct activation of pain receptors by external stimuli.

Value Proposition for Manufacturers

• IP Protection: Covered under filed U.S. Provisional Intellectual Property.
• Market Differentiation: Shifts standard-of-care from transient liquid rinses to a true localized, high-retention structural matrix.
• Regulatory Streamlining: Designed using biocompatible and industry-accepted polymeric components to enable an efficient regulatory pathway.